Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO MAP 2022 | The entry of lymphocytes into the tumor via high endothelial venules

Jean-Philippe Girard • 13 Oct 2022
ESMO MAP 2022
General

Jean-Philippe Girard, PhD, CNRS-Université de Toulouse III, Toulouse, France, talks on tumor-associated high endothelial venules (TA-HEVs), a specific subset of blood vessels that mediate the entry of lymphocytes into the tumor This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jean-Philippe Girard

1:53
Increasing the recruitment of high endothelial venules (HEVs) into the tumor
Jean-Philippe Girard • 13 Oct 2022
4:17
HEVs and lymphocyte recruitment in tumors in response to immune checkpoint blockade
Jean-Philippe Girard • 13 Oct 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals